Communiqués OliX Pharmaceuticals, Inc

Actions

Cours en clôture Korea S.E. Autres places de cotation 23/07/2026			Varia. 5j.	Varia. 1 janv.
113 800,00 ^KRW	+10,49%		-13,26%	-18,95%

15/05	OliX Pharmaceuticals, Inc publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI
01/04	Ollix (226950) reçoit un avis favorable de délivrance de brevet de l'USPTO pour son traitement de la DMLA	CI

04/06	OliX Pharmaceuticals Secures KRW 110 Billion Investment from BOLD, L'Oreal Corporate Venture Capital Fund, and Weiss, U.S. Hedge Fund	AQ
23/11/22	OliX Pharmaceuticals Publishes Preclinical Research Demonstrating OLX104C's Potential as an Effective Treatment for Hair Loss	AQ
07/02/22	OliX Pharmaceuticals to Present at SMi 13th Annual RNA Therapeutics Conference	GL
03/01/22	OliX Pharmaceuticals to Participate in BIO Partnering at JPM and Biotech Showcase 2022 Conferences	GL
20/10/21	OliX Pharmaceuticals : Enters Agreement with Pharmaron to Advance Non-clinical Toxicology Testing for Hepatitis B Candidate OLX703A	GL